SERGAS advances clinical research in Europe with a pioneering digital platform
The Galician Health Service (SERGAS), one of Spain’s leading public healthcare systems and a key contributor to clinical research, identified the need for a digital framework that could support operational excellence in this field.
SERGAS partnered with NTT DATA to build Innovatrial, an AWS‑based digital platform that applies AI and blockchain to modernize clinical research. The pre‑commercial procurement solution accelerates patient recruitment, strengthens coordinated collaboration across research networks and improves the speed and quality of clinical‑evidence generation.
80%
Up to 80% of clinical research processes digitalized
3 million
Impact across a population of 3 million
Connecting fragmented data to transform clinical research
Like other healthcare organizations, SERGAS faced significant structural challenges: improving the quality of health data for secondary use, reducing dependence on manual processes, identifying eligible patients and managing the administrative load created by increasingly demanding regulatory frameworks such as the Clinical Trials Regulation and Clinical Trials Information System (CTIS).
Additional challenges included combining structured and unstructured data, reducing the time required to launch projects and trials, improving evidence generation and meeting the need for consistently transparent and auditable processes in accordance with Good Clinical Practice (GCP) and General Data Protection Regulation (GDPR).
Collectively, these constraints slowed study start‑up, made coordination across centers harder and limited how quickly organizations could generate evidence with the required security at a moment when accelerating clinical research had become a strategic priority.
SERGAS needed a solution that would modernize its clinical research model, strengthen coordination across centers and ensure secure data use while supporting innovation and speeding patient access to new treatments. These priorities aligned with the broader digital health ecosystem roadmap for Galicia’s public healthcare system (SPSG).
Meeting these requirements called for an ecosystem that connects healthcare delivery with clinical research, integrates dispersed information, streamlines the identification of patients eligible for studies and supports compliance with stringent regulations. Importantly, the solution needed to integrate seamlessly with the organization’s existing digital architecture.
“
In a global digital transformation process, where we are witnessing an exponential increase in computing power and data processing capabilities, the healthcare sector has an opportunity to improve outcomes at every level. It is necessary to invest in new tools that must be available to healthcare professionals to safely transform the enormous amount of data generated every day into knowledge through research.
”Bringing clinical research together with AI, cloud and blockchain
Led by the Regional Ministry of Health of the Government of Galicia and funded by the Center for Technological Development and Innovation (CDTI), the project tasked NTT DATA with building a solution that uses AWS cloud infrastructure, generative AI models and blockchain to support next‑generation clinical research.
Innovatrial was built to manage the complexity of SERGAS’ digital ecosystem, bringing data, processes and teams into a unified environment that prevents silos and delivers the interoperability required for modern clinical research.
The platform aligns with the Estratexia Galega de Saúde 2030 and the Plan de Transformación y Saúde Digital, seamlessly connecting healthcare delivery with clinical research to help turn innovation into direct patient benefits.
Its modular, interoperable architecture uses standards including HL7/FHIR, CDISC, OMOP and DICOMweb, supporting a consistent flow of information among hospitals, researchers and research support units.
Innovatrial uses AI to make it faster and easier to identify eligible patients through natural language processing, automated cohort generation and real-time alerts. It also uses AWS services, including S3, Glue, Athena and SageMaker and security services such as identity and access management and CloudTrail. AWS RES provides isolated environments for analyzing sensitive data in compliance with GCP and GDPR.
Blockchain technology strengthens traceability by providing immutable records and supporting regulatory transparency.
Together, these capabilities position Innovatrial as a strategic link between SERGAS’ healthcare delivery and research environments, supporting a more efficient, interoperable and adaptable clinical research model.
Developed and validated under a pre-commercial procurement contract in collaboration with CDTI, SERGAS and its associated research foundations, the solution is now ready for its next phase of deployment and implementation.
“
Innovatrial is the result of our joint work with SERGAS, based on an understanding of its complexity and alignment with its strategic vision. The platform helps speed up the generation of clinical evidence and shorten the path to new therapies, combining technology, interoperability and purpose to strengthen public healthcare research.
”From weeks to minutes: speeding up clinical research
The Innovatrial platform demonstrates several potential benefits:
- Digitalization of up to 80% of clinical research processes
- Reduction in patient recruitment time from weeks to minutes
- Greater regulatory agility through centralized documentation
- Alignment with CTIS, DARWIN EU and Clinical Evidence 2030, to help ensure evidence is ready for European frameworks
- Impact across a population of 3 million people
- Support for decentralized and hybrid models that give patients more control over their data
These validated results represent a meaningful advance in how SERGAS designs, conducts and monitors clinical studies. They improve operational efficiency, strengthen regulatory transparency and speed patient access to new therapies.
Next steps
Following the implementation of Innovatrial, SERGAS is preparing for the progressive expansion of the platform to additional clinical areas and research units. The next phase focuses on integration with European federated research networks, enabling participation in collaborative initiatives and interoperable data ecosystems that reinforce Galicia’s role in international clinical research. Plans also include adding generative AI capabilities to accelerate study design, feasibility assessment and early‑stage optimization, supporting a more agile, predictive research model built for future requirements.
About SERGAS
The Galician Health Service (SERGAS) manages public healthcare in Galicia and serves approximately 3 million people. Its network includes 14 hospitals and more than 450 primary care centers, staffed by more than 48,000 professionals. In addition to providing healthcare services, SERGAS plays a strategic role in advancing clinical research in Spain, supporting scientific evidence generation and participation in international studies on new treatments.
Industry
Healthcare
Headquarters
Spain